Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
Site Announcement

Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.

Investors
  • Overview
  • Corporate News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Leadership
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
    • IRS Form 8937 for 2019 Reverse Stock Split
    • IRS Form 8937 for 2023 Reverse Stock Split
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Governance Documents
  • Analyst Coverage

Press Releases

  • Corporate News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Jul 21, 2015

Aethlon Medical to Ring the Nasdaq Stock Market Closing Bell on July 24th

Jul 13, 2015

Aethlon Medical Begins Trading on the Nasdaq Capital Market

Jul 8, 2015

Aethlon Medical Announces Nasdaq Capital Market Listing Approval

Jun 24, 2015

Aethlon Medical Announces $6 Million Equity Investment

Jun 11, 2015

Aethlon Medical Discloses Upcoming Presentations

Jun 9, 2015

Aethlon Medical Announces Resignation of Inside Director to Comply with NASDAQ Corporate Governance Requirements

Jun 5, 2015

Aethlon Medical to Present at the BIO International Convention

Jun 4, 2015

Aethlon Medical Expands Clinical Research Studies to Include Chikungunya Virus

May 26, 2015

Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference

May 13, 2015

Aethlon Medical Announces Health Canada Approval of Ebola Treatment Protocol

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.